These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16138625)

  • 1. [Recall actions for implantable defibrillators -- how do you counsel your defibrillator patients now?].
    Lüderitz B
    MMW Fortschr Med; 2005 Aug; 147(33-34):8-9. PubMed ID: 16138625
    [No Abstract]   [Full Text] [Related]  

  • 2. Lessons from the failure and recall of an implantable cardioverter-defibrillator.
    Hauser RG; Maron BJ
    Circulation; 2005 Sep; 112(13):2040-2. PubMed ID: 16172264
    [No Abstract]   [Full Text] [Related]  

  • 3. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.
    Tung R; Zimetbaum P; Josephson ME
    J Am Coll Cardiol; 2008 Sep; 52(14):1111-21. PubMed ID: 18804736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transvenous implantable cardioverter-defibrillator leads: the weakest link.
    Maisel WH
    Circulation; 2007 May; 115(19):2461-3. PubMed ID: 17502585
    [No Abstract]   [Full Text] [Related]  

  • 5. The year in clinical electrophysiology.
    Scheinman MM; Keung E
    J Am Coll Cardiol; 2006 Mar; 47(6):1207-13. PubMed ID: 16545653
    [No Abstract]   [Full Text] [Related]  

  • 6. The implantable cardiac defibrillator--treatment at last for sudden cardiac death?
    Hider P
    N Z Med J; 1999 Mar; 112(1084):85-7. PubMed ID: 10210292
    [No Abstract]   [Full Text] [Related]  

  • 7. Implantable cardioverter-defibrillator product reliability: recalling lessons from a tragic case.
    Estes NA
    Heart Rhythm; 2005 Jul; 2(7):684-6. PubMed ID: 15992720
    [No Abstract]   [Full Text] [Related]  

  • 8. A fatal complication of ICD therapy due to lead failure.
    Theuns DA; Szili-Torok T; Jordaens LJ
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):E48. PubMed ID: 18554196
    [No Abstract]   [Full Text] [Related]  

  • 9. When life-saving devices terminate life.
    Catanchin A; Anderson L; Jones S; Ward D
    J Cardiovasc Electrophysiol; 2008 Mar; 19(3):316-8. PubMed ID: 18266677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare coverage of ICDs.
    McClellan MB; Tunis SR
    N Engl J Med; 2005 Jan; 352(3):222-4. PubMed ID: 15659721
    [No Abstract]   [Full Text] [Related]  

  • 11. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality risk of Fidelis management.
    Faddis MN
    J Am Coll Cardiol; 2011 Jul; 58(3):284-5. PubMed ID: 21737020
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defibrillation threshold testing in the 21st century: necessary or not?
    Vlay SC
    Pacing Clin Electrophysiol; 2009 May; 32(5):565-6. PubMed ID: 19422574
    [No Abstract]   [Full Text] [Related]  

  • 15. Atrial fibrillation in patients with implantable defibrillators.
    Sakhuja R; Shah AJ; Keebler M; Thakur RK
    Cardiol Clin; 2009 Feb; 27(1):151-61, ix-x. PubMed ID: 19111771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troubleshooting implantable cardioverter-defibrillator related problems.
    van Erven L; Schalij MJ
    Heart; 2008 May; 94(5):649-60. PubMed ID: 18411360
    [No Abstract]   [Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillator lead failure: how weak is the link?
    Brinker JA
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defibrillation testing at ICD implantation: are we asking the wrong question?
    Gold MR; Kroll MW; Ellenbogen KA
    Pacing Clin Electrophysiol; 2009 May; 32(5):567-9. PubMed ID: 19422575
    [No Abstract]   [Full Text] [Related]  

  • 19. The Food and Drug Administration's regulation of risk disclosure for implantable cardioverter defibrillators: has technology outpaced the Agency's regulatory framework?
    Basile EM; Lorell BH
    Food Drug Law J; 2006; 61(2):251-72. PubMed ID: 16903031
    [No Abstract]   [Full Text] [Related]  

  • 20. ICDs: dealing with less than perfect.
    Wilkoff BL
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):796-7. PubMed ID: 16050841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.